Logo image of SYNL

SYNALLOY CORP (SYNL) Stock Fundamental Analysis

NASDAQ:SYNL - Nasdaq - US8715651076 - Common Stock - Currency: USD

15.57  +2.29 (+17.24%)

Fundamental Rating

2

SYNL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 155 industry peers in the Metals & Mining industry. SYNL may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SYNL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SYNL was profitable.
SYNL Yearly Net Income VS EBIT VS OCF VS FCFSYNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M 20M -20M 30M

1.2 Ratios

Industry RankSector Rank
ROA 10.15%
ROE 24.04%
ROIC 14.9%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SYNL Yearly ROA, ROE, ROICSYNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 -10 -20 -30

1.3 Margins

Industry RankSector Rank
OM 11.18%
PM (TTM) 7.72%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SYNL Yearly Profit, Operating, Gross MarginsSYNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 -10 15

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SYNL is creating some value.
The number of shares outstanding for SYNL has been increased compared to 1 year ago.
SYNL has a better debt/assets ratio than last year.
SYNL Yearly Shares OutstandingSYNL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
SYNL Yearly Total Debt VS Total AssetsSYNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

SYNL has an Altman-Z score of 3.19. This indicates that SYNL is financially healthy and has little risk of bankruptcy at the moment.
SYNL has a Debt/Equity ratio of 0.57. This is a neutral value indicating SYNL is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 3.19
ROIC/WACC1.77
WACC8.4%
SYNL Yearly LT Debt VS Equity VS FCFSYNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M

2.3 Liquidity

SYNL has a Current Ratio of 2.97. This indicates that SYNL is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.18 indicates that SYNL should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 1.18
SYNL Yearly Current Assets VS Current LiabilitesSYNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

SYNL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 209.27%, which is quite impressive.
The Earnings Per Share has been growing by 94.56% on average over the past years. This is a very strong growth
The Revenue has grown by 51.80% in the past year. This is a very strong growth!
Measured over the past years, SYNL shows a quite strong growth in Revenue. The Revenue has been growing by 19.28% on average per year.
EPS 1Y (TTM)209.27%
EPS 3Y13.3%
EPS 5Y94.56%
EPS Q2Q%890%
Revenue 1Y (TTM)51.8%
Revenue growth 3Y6.03%
Revenue growth 5Y19.28%
Sales Q2Q%66.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SYNL Yearly Revenue VS EstimatesSYNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
SYNL Yearly EPS VS EstimatesSYNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.17 indicates a rather cheap valuation of SYNL.
SYNL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.25.
Industry RankSector Rank
PE 5.17
Fwd PE N/A
SYNL Price Earnings VS Forward Price EarningsSYNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.33
SYNL Per share dataSYNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SYNL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SYNALLOY CORP

NASDAQ:SYNL (8/10/2022, 8:14:51 PM)

15.57

+2.29 (+17.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-09 2022-08-09/amc
Earnings (Next)11-07 2022-11-07
Inst Owners21.29%
Inst Owner Change1.49%
Ins Owners15.53%
Ins Owner Change0%
Market Cap159.18M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.17
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB N/A
EV/EBITDA 4.33
EPS(TTM)3.01
EY19.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS37.28
BVpS11.97
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA 10.15%
ROE 24.04%
ROCE N/A
ROIC 14.9%
ROICexc N/A
ROICexgc 16.85%
OM 11.18%
PM (TTM) 7.72%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 1.18
Altman-Z 3.19
F-Score6
WACC8.4%
ROIC/WACC1.77
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)209.27%
EPS 3Y13.3%
EPS 5Y94.56%
EPS Q2Q%890%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.8%
Revenue growth 3Y6.03%
Revenue growth 5Y19.28%
Sales Q2Q%66.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A